• DOI:10.1007/s40122-015-0039-5
Corpus ID: 16646746

Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data

@article{Riederer2015TranscutaneousSN,
  title={Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data},
  author={F. Riederer and S. Penning and J. Schoenen},
  journal={Pain and Therapy},
  year={2015},
  volume={4},
  pages={135 - 147}
}

F. Riederer, S. Penning, J. Schoenen

Published 2015

Medicine

Pain and Therapy

So far, among the different non-invasive neurostimulation methods, only transcutaneous supraorbital nerve stimulation (t-SNS) with the Cefaly® (Cefaly Technology sprl, Herstal, Belgium) device has randomized controlled trial-based evidence for safety and efficacy and obtained American Food and Drug Administration approval for the prevention of episodic migraine. [...] Key Result In a double-blinded, randomized, sham-controlled trial on 67 episodic migraine patients (mean pre-treatment migraine days/month: 6.9…Expand Abstract

View on Springer

link.springer.com

Save to Library

Create Alert

Cite

Launch Research Feed